February 17, 2016
Combining the high sensitivity of PET for molecular and cellular processes with the functional and anatomical information from MR results in a promising hybrid molecular imaging modality.
There is perhaps no technology currently being developed in the field of radiology that is more popular in scientific journals — and with more long-range potential — than PET/MR. Cancer and Alzheimer’s Disease, as well as other forms of dementia, are among the major population health issues that these merged technologies may help us diagnose.
At the Mid-Winter Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Dr. Jacob Dubroff from the University of Pennsylvania discussed this valuable — and expensive — new technology.